Hosted on MSN1mon
Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial showsLynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe ... at the Dana-Farber Cancer Institute in Boston, said in the news release. Dr. Douglas Marks ...
Mr. Kennedy has referred clients to the firm in cases claiming injuries from the Gardasil vaccine, a Merck product that is meant to prevent cervical cancer that can be caused by the human ...
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results